Efficacy of repeated PSMA PET-directed radiotherapy for oligorecurrent prostate cancer after initial curative therapy

PURPOSE: To assess the outcome of prostate cancer (PCa) patients diagnosed with oligorecurrent disease and treated with a first and a second PSMA (prostate-specific membrane antigen ligand) PET(positron-emission tomography)-directed radiotherapy (RT). PATIENTS AND METHODS: Thirty-two patients with o...

Descripción completa

Detalles Bibliográficos
Autores principales: Henkenberens, Christoph, Oehus, Ann-Kathrin, Derlin, Thorsten, Bengel, Frank, Ross, Tobias L., Kuczyk, Markus A., Janssen, Stefan, Christiansen, Hans, von Klot, Christoph A. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7581615/
https://www.ncbi.nlm.nih.gov/pubmed/32399639
http://dx.doi.org/10.1007/s00066-020-01629-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7581615/
https://www.ncbi.nlm.nih.gov/pubmed/32399639
http://dx.doi.org/10.1007/s00066-020-01629-5

Ejemplares similares